Gruskin Daniel 4
4 · LogicBio Therapeutics, Inc. · Filed May 20, 2021
Insider Transaction Report
Form 4
Gruskin Daniel
Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to buy)
2021-05-19+60,000→ 60,000 totalExercise: $4.33Exp: 2031-05-19→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The options were granted by the Issuer pursuant to its 2018 Equity Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal monthly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.